Multivariate analysis of factors affecting overall survival
| . | Relative risk of death (95% CI) . | P overall . |
|---|---|---|
| Main effect | < .001† | |
| 1989-1994 | 1.00 (reference) | |
| 1995-2000 | 0.83 (0.69-1.01) | .05 |
| 2001-2005* | ||
| ≤ 6 mo after transplantation | 0.41 (0.32-0.53) | < .001 |
| > 6 mo after transplantation | 0.98 (0.76-1.26) | .86 |
| Other significant factors | ||
| Age, continuous | 1.01 (1.00-1.02) | .04 |
| Time from diagnosis to transplant | ||
| ≤ 24 mo | 1.00 (reference) | |
| > 24 mo | 1.24 (1.06-1.45) | .01 |
| Donor | ||
| HLA-identical sibling | 1.00 (reference) | |
| Others | 1.79 (1.52-2.11) | < .001 |
| . | Relative risk of death (95% CI) . | P overall . |
|---|---|---|
| Main effect | < .001† | |
| 1989-1994 | 1.00 (reference) | |
| 1995-2000 | 0.83 (0.69-1.01) | .05 |
| 2001-2005* | ||
| ≤ 6 mo after transplantation | 0.41 (0.32-0.53) | < .001 |
| > 6 mo after transplantation | 0.98 (0.76-1.26) | .86 |
| Other significant factors | ||
| Age, continuous | 1.01 (1.00-1.02) | .04 |
| Time from diagnosis to transplant | ||
| ≤ 24 mo | 1.00 (reference) | |
| > 24 mo | 1.24 (1.06-1.45) | .01 |
| Donor | ||
| HLA-identical sibling | 1.00 (reference) | |
| Others | 1.79 (1.52-2.11) | < .001 |